MoneyWorks4Me

Neuland Laboratories - Quaterly Results

13 May 2026 Evaluate
The total revenue for the March 2026 quarter zoomed 136.40% to Rs. 7762.50 millions as compared to Rs. 3283.60 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 666.29% to Rs. 2125.23  millions  from Rs. 277.34 millions in previous same quarter.OP of the company witnessed a marginal growth to 3193.60 millions from 582.18 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 7762.50 3283.60 136.40 20229.85 14768.37 36.98 20229.85 14768.37 36.98
Other Income 124.57 74.64 66.89 301.64 205.09 47.08 301.64 205.09 47.08
PBIDT 3193.60 582.18 448.56 6034.09 3428.08 76.02 6034.09 3428.08 76.02
Interest 72.31 23.46 208.23 239.45 82.96 188.63 239.45 82.96 188.63
PBDT 3121.29 558.72 458.65 5794.64 4109.16 41.02 5794.64 4109.16 41.02
Depreciation 250.87 168.90 48.53 917.30 655.42 39.96 917.30 655.42 39.96
PBT 2870.42 389.82 636.34 4877.34 3453.74 41.22 4877.34 3453.74 41.22
TAX 745.19 112.48 562.51 1246.29 859.48 45.01 1246.29 859.48 45.01
Deferred Tax -22.79 53.11 -142.91 -42.55 122.95 -134.61 -42.55 122.95 -134.61
PAT 2125.23 277.34 666.29 3631.05 2594.26 39.96 3631.05 2594.26 39.96
Equity 129.00 129.00 0.00 129.00 129.00 0.00 129.00 129.00 0.00
PBIDTM(%) 41.14 17.73 132.05 29.83 23.21 28.50 29.83 23.21 28.50
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..